Attenuation of G Protein-mediated Inhibition of N-type Calcium Currents by Expression of Caveolins in Mammalian NG108-15 Cells
Overview
Affiliations
1. Caveolins are integral proteins of glycolipid/cholesterol-rich plasmalemmal caveolae domains, where, they may function as a plasma membrane scaffold onto which many classes of signalling molecules, including receptors and heterotrimeric G proteins, can assemble. To ascertain whether caveolins influence G protein-mediated signal transduction, we stably expressed caveolin-1 and -3 isoforms in the neuroblastoma x glioma NG108-15 hybrid cell line, lacking endogenous caveolins. Subsequently, using whole-cell voltage clamp methods, we examined whether the modulation of N-type voltage-gated Ca2+ channels by G(o) protein-coupled, delta-type opioid receptors might be affected by recombinant caveolin expression. 2. In transfected NG108-15 cells, caveolins localized at the plasma membrane and, upon subcellular fractionation on sucrose density gradients, they co-localized in Triton-resistant, low buoyancy fractions, with endogenous G(o) protein alpha-subunits. 3. The voltage-dependent inhibition of omega-conotoxin GVIA-sensitive Ba2+ currents following either activation of delta-opioid receptors by the agonist [o-pen2,o-pen5]-enkephalin (DPDPE), or direct stimulation of G proteins with guanosine 5'-O-(thiotriphosphate) (GTPgammaS) was significantly attenuated in caveolin-expressing cells. The kinetics of Ca2+ channel inhibition were also modified by caveolins. 4. Overall, these results suggest that caveolins may negatively affect G protein-dependent regulation of voltage-gated N-type Ca2+ channels, presumably by causing a reduction of the available pool of activated G proteins.
Talin-1 interaction network promotes hepatocellular carcinoma progression.
Chen P, Zheng X, Zhou Y, Xu Y, Zhu L, Qian Y Oncotarget. 2017; 8(8):13003-13014.
PMID: 28099903 PMC: 5355072. DOI: 10.18632/oncotarget.14674.
Molecular Pharmacology of δ-Opioid Receptors.
Gendron L, Cahill C, Von Zastrow M, Schiller P, Pineyro G Pharmacol Rev. 2016; 68(3):631-700.
PMID: 27343248 PMC: 4931872. DOI: 10.1124/pr.114.008979.
Licon Y, Leandro D, Romero-Mendez C, Rodriguez-Menchaca A, Sanchez-Armass S, Meza U Pflugers Arch. 2014; 467(8):1699-709.
PMID: 25204428 DOI: 10.1007/s00424-014-1605-0.
Huang P, Xu W, Yoon S, Chen C, Chong P, Liu-Chen L Biochem Pharmacol. 2006; 73(4):534-49.
PMID: 17141202 PMC: 2583444. DOI: 10.1016/j.bcp.2006.10.032.
Toselli M, Biella G, Taglietti V, Cazzaniga E, Parenti M Biophys J. 2005; 89(4):2443-57.
PMID: 16040758 PMC: 1366744. DOI: 10.1529/biophysj.105.065623.